FDA Clearance Tracker · P240020
TOUCH® CMC 1 Prosthesis
Last checked: Nov 19, 2026Latest source record: Jul 10, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jul 10, 2025
Approved
Time to decision
398 days
Received Jun 7, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240020
- Device name
- TOUCH® CMC 1 Prosthesis
- Applicant
- Keri Medical SA
- Applicant location
- 1228 Plan-Les-Ouates
- Received
- Jun 7, 2024
- Decided
- Jul 10, 2025
- Decision
- Approved
- Supplements
- 6 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
TOUCH® CMC 1 Prosthesis is indicated for 1st carpometacarpal (CMC) primary total joint replacement (arthroplasty) in patients with symptomatic Eaton-Littler stage II or III osteoarthritis (OA).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SFA (Prosthesis, finger, semi-constrained, metal/polymer).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Keri Medical SA
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263582 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Prosthesis, Finger, Constrained, Polymer (KYJ) · Orthopedic Surgery
K211385 · Decided Jul 27, 2022 · 449 days after receipt
Device type: Prosthesis, Finger, Constrained, Polymer (KYJ) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.